01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

#HVO hVIVO PLC – Appointment of Non-Executive Director December 18, 2025 – Posted in: hVIVO (HVO)

hVIVO plc (AIM: HVO), a full-service early phase Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces the appointment of Richard Cotton as Independent Non-Executive Director, effective today. Richard will also serve as Chair of the Audit Committee and as a member of the Remuneration and Nominations Committees.   Richard brings extensive Board-level and financial expertise, including experience serving as Chair, Audit Chair and Senior Independent Director, as well as holding advisory…

Continue reading

#EGT European Green Transition PLC – Interim Results and M&A Strategy Update September 24, 2025 – Posted in: European Green Transition Plc (EGT)

European Green Transition (AIM: EGT), a company which aims to capitalise on the opportunities created by the green energy transition in Europe, announces its unaudited results for the six months ended 30 June 2025.   Highlights ·    Extension of the Olserum Rare Earth Elements (“REE”) project licenses in Sweden until June 2029, following the successful completion of the Olserum REE drill programme in H2 2024 which confirmed the district scale potential for REEs at Olserum ·    Successful…

Continue reading

#VELA Vela Technologies PLC – Quarterly Investment Update June 10, 2024 – Posted in: Vela Technologies Plc (VELA)

The Board of Vela (AIM:VELA), an AIM-quoted investing company focused on early-stage and pre-IPO disruptive technology investments, is pleased to report an update for the quarter ended 31 March 2024. Key numbers as at 31 March 2024* ·      The value of Vela’s total assets (including cash) decreased during the quarter by £640,000 (10%) to £5,540,000 (quarter to 31 December 2023 – a decrease of £639,000 to £6,180,000 (9%)). ·      Vela’s portfolio comprised a total of…

Continue reading

#TSP TruSpine Technologies PLC – Final Results September 29, 2023 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless,” spinal (vertebral) stabilisation systems, reports its full year results for the year ended 29 March 2023.   The Company continues to be in a pre-revenue development phase and remains loss making at this stage of its development. The loss before taxation for the year was £853k (2022: £941k) after administrative expenses of £846k (2022: £938k). The R&D tax…

Continue reading

#HVO hVIVO PLC – Final results April 25, 2023 – Posted in: hVIVO (HVO)

hVIVO plc (AIM & Euronext: HVO), (formerly Open Orphan plc) a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces its audited results for the 12 months ended 31 December 2022.   Financial highlights ·    Revenue up 30% to £50.7m (2021: £39.0m) ·    EBITDA increased threefold to £9.1m (2021: £2.9m) ·    EBITDA margins of 17.9% (2021: 7.4%), ahead of guidance due…

Continue reading

#VELA Vela Technologies PLC investee co. #ENSI Ensilica PLC – Unaudited Half Year Results February 17, 2023 – Posted in: Vela Technologies Plc (VELA)

EnSilica (AIM: ENSI), a leading mixed signal chipmaker, announces half year results for the six months ended 30 November 2022 (“H1 FY23”).   Financial Highlights   ·    Revenue up 23.5% to £8.6 million (H1 FY22: £7.0 million) ·    Adjusted operating profit up to £0.15 million (H1 FY22: £0.17 million loss) ·    Gross margin 42.5% (H1 FY22: 26.7%) ·    Adjusted EBITDA up significantly to £0.66 million (H1 FY22: loss of £0.08 million) ·    Cash and cash equivalents at 30 November of…

Continue reading